India Creatine Supplements Market Size & Outlook, 2025-2033
India Creatine Supplements Market Insights
- Based on Deep Market Insights findings, the India Creatine Supplements Market reached USD 37.61 Million in 2024 and is estimated to attain USD 187.14 Million by 2033.
- From 2026 to 2033, the India market is expected to grow at a steady CAGR of 20.1%.
- Within the Product/Form category, Creatine monohydrate dominated in 2024 in terms of market size contribution.
- Over the forecast period, Capsules & powders is forecasted to deliver the fastest growth, positioning it as the most lucrative Product/Form segment.
![India Creatine Supplements Market Share & Growth Report By [2033]](https://deepmarketinsights.com/uploads/charts/india-creatine-supplements-market-india-productform-30387.png)
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- India contributed 3.62% to the global Creatine Supplements Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Creatine Supplements Market.
- In Asia Pacific, China is projected to capture the leading share of market size by 2033.
- Among Asia Pacific markets, Singapore is expected to post the fastest growth, reaching USD 37.34 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 37.61 Million |
| Market Size In 2033 | USD 187.14 Million |
| Largest segment | Creatine monohydrate |
| Units | Revenue in USD Million |
| CAGR | 20.1% (2025-2033) |
| Segmnetation Covered | |
| Product/Form |
|
| End User |
|
| Distribution |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
India Creatine Supplements Market Product/Form 2025-2033 (USD Million)
| Product/Form | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Creatine monohydrate | XX.x | XX.x | XX.x | 18.11 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Creatine HCl | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Buffered & blends | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Capsules & powders | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
India Creatine Supplements Market End User 2025-2033 (USD Million)
| End User | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Athletes & sports | XX.x | XX.x | XX.x | 18.88 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Fitness enthusiasts | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Medical/older adults | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
India Creatine Supplements Market Distribution 2025-2033 (USD Million)
| Distribution | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E-commerce | XX.x | XX.x | XX.x | 17.3 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Pharmacies & retail | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Specialty sports stores | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.